SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-116296
Filing Date
2021-04-14
Accepted
2021-04-14 16:16:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d937458ddefa14a.htm DEFA14A 19893
2 GRAPHIC g937458g54s97.jpg GRAPHIC 79808
3 GRAPHIC g937458g94m61.jpg GRAPHIC 225260
  Complete submission text file 0001193125-21-116296.txt   440965
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39509 | Film No.: 21825894
SIC: 2834 Pharmaceutical Preparations